Akeylink Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $87.4M

  • Investors
  • 7

Akeylink General Information

Description

Manufacturer of antiviral and liver disease therapeutics designed to treat viral infections, chronic liver disorders, and related diseases. The company offers small-molecule antiviral drugs and clinical-stage pipelines targeting viral proteases, hepatitis B viral proteins, liver fibrosis, and cancer-related pathways, enabling patients and healthcare providers to access targeted therapies for infectious and liver diseases.

Contact Information

Website
www.akeylink.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Comprehensive Office Building, Buildings 1-7, Fuyuan Industrial Park
  • Zherong County
  • Ningde, Fujian 355300
  • China
+86 400
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 2nd Floor, Comprehensive Office Building, Buildings 1-7, Fuyuan Industrial Park
  • Zherong County
  • Ningde, Fujian 355300
  • China
+86 400

Akeylink Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akeylink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC $87.4M Upcoming Generating Revenue
2. Early Stage VC (Series B) 16-Oct-2025 Completed Generating Revenue
1. Early Stage VC 14-Feb-2023 $32.4M $32.4M Completed Generating Revenue
To view Akeylink’s complete valuation and funding history, request access »

Akeylink Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
People's Capital Growth/Expansion Minority
Shanghai Huamin Investment Management Growth/Expansion Minority
Fujian Huaxing Venture Capital Venture Capital Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Ningde Huiju Private Equity Fund Management Growth/Expansion Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Akeylink FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process